Foghorn Therapeutics Inc (FHTX)

Jan 07, 2026

Can Foghorn Therapeutics Inc. stock reach $100 price targetStop Loss Placement Tips & Low Cost Capital Gains - ulpravda.ru

Jan 07, 2026

Jan 06, 2026

Will Foghorn Therapeutics Inc. stock continue upward momentum2026 world cup usa national team third place match key players transition play group prediction analysis - ulpravda.ru

Jan 06, 2026

Jan 06, 2026

Is Foghorn Therapeutics Inc. stock a bargain at current levels2026 world cup usa national team group stage top scorers possession football odds analysis expert opinion - ulpravda.ru

Jan 06, 2026

Dec 26, 2025

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat

Dec 26, 2025

Dec 23, 2025

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected - simplywall.st

Dec 23, 2025

Dec 21, 2025

Why Foghorn Therapeutics Inc. stock is recommended by analystsWatch List & Community Consensus Picks - Улправда

Dec 21, 2025

Dec 20, 2025

Is Foghorn Therapeutics Inc. stock resilient to inflation2025 Support & Resistance & Real-Time Chart Breakout Alerts - Улправда

Dec 20, 2025

Dec 20, 2025

What momentum indicators show for Foghorn Therapeutics Inc. stockBuy Signal & Weekly Momentum Stock Picks - Улправда

Dec 20, 2025

Dec 20, 2025

BTIG Research Begins Coverage on Foghorn Therapeutics (NASDAQ:FHTX) - Defense World

Dec 20, 2025

Dec 20, 2025

Wall Street Zen Upgrades Foghorn Therapeutics (NASDAQ:FHTX) to "Buy" - MarketBeat

Dec 20, 2025

Dec 19, 2025

Is Foghorn Therapeutics Inc. stock supported by strong fundamentalsJuly 2025 Decliners & AI Forecast Swing Trade Picks - bolumsonucanavari.com

Dec 19, 2025

Dec 19, 2025

How Foghorn Therapeutics Inc. stock performs after earningsJuly 2025 Drop Watch & Reliable Breakout Stock Forecasts - Улправда

Dec 19, 2025

Dec 19, 2025

Foghorn Therapeutics (NASDAQ:FHTX) Earns Buy Rating from Analysts at BTIG Research - MarketBeat

Dec 19, 2025

Dec 19, 2025

Will Foghorn Therapeutics Inc. stock deliver better than expected guidanceWeekly Stock Recap & Proven Capital Preservation Tips - Улправда

Dec 19, 2025

Dec 19, 2025

Here's Why We're Watching Foghorn Therapeutics' (NASDAQ:FHTX) Cash Burn Situation - Sahm

Dec 19, 2025

Dec 18, 2025

BTIG Initiates Coverage of Foghorn Therapeutics (FHTX) with Buy Recommendation - Nasdaq

Dec 18, 2025

Dec 18, 2025

3 Cancer Stocks to Buy Amid Rapid Advances in Cancer Treatment - Yahoo Finance

Dec 18, 2025

Dec 18, 2025

BTIG Research Initiates Coverage on Foghorn Therapeutics With Buy Rating, $11 Price Target - MarketScreener

Dec 18, 2025

Dec 18, 2025

BTIG Initiates Coverage on FHTX with a Buy Rating and $11.00 Pri - GuruFocus

Dec 18, 2025

Dec 18, 2025

Support Test: What momentum indicators show for Foghorn Therapeutics Inc. stockPortfolio Return Report & Low Risk Investment Opportunities - Улправда

Dec 18, 2025

Dec 18, 2025

BTIG initiates Foghorn Therapeutics stock with Buy rating on cancer pipeline - Investing.com Canada

Dec 18, 2025

Dec 18, 2025

Foghorn Therapeutics (NASDAQ:FHTX) vs. Arcadia Biosciences (NASDAQ:RKDA) Head to Head Analysis - Defense World

Dec 18, 2025

Dec 16, 2025

Estrella Immunopharma (NASDAQ:ESLA) & Foghorn Therapeutics (NASDAQ:FHTX) Head-To-Head Contrast - Defense World

Dec 16, 2025

Dec 11, 2025

Platform Technologies Drive $211B Surge in Precision Cancer Treatment - marketscreener.com

Dec 11, 2025

Dec 06, 2025

Analyst Confidence Rises for Foghorn Therapeutics Following Leadership and Pipeline Updates - AD HOC NEWS

Dec 06, 2025

Dec 06, 2025

Foghorn Therapeutics (NASDAQ:FHTX) Stock Rating Lowered by Wall Street Zen - Defense World

Dec 06, 2025

Dec 05, 2025

Is Foghorn Therapeutics Inc. stock attractive for hedge fundsJobs Report & AI Driven Stock Reports - Newser

Dec 05, 2025

Dec 04, 2025

Stifel Initiates Coverage of Foghorn Therapeutics (FHTX) with Buy Recommendation - Nasdaq

Dec 04, 2025

Dec 04, 2025

Stifel Initiates Coverage on FHTX with a 'Buy' Rating | FHTX Sto - GuruFocus

Dec 04, 2025

Dec 04, 2025

Foghorn Therapeutics Appoints Interim CFO Jeff Sacher - TipRanks

Dec 04, 2025

Dec 04, 2025

Foghorn Therapeutics Inc appoints Jeff Sacher as interim CFO - marketscreener.com

Dec 04, 2025

Dec 04, 2025

Foghorn Therapeutics appoints Jeff Sacher as interim CFO and treasurer By Investing.com - Investing.com Nigeria

Dec 04, 2025

Dec 04, 2025

Foghorn Therapeutics appoints Jeff Sacher as interim CFO and treasurer - Investing.com

Dec 04, 2025

Dec 04, 2025

Why Foghorn Therapeutics Inc. stock remains on buy listsJuly 2025 Price Swings & Reliable Momentum Entry Alerts - Newser

Dec 04, 2025

Dec 03, 2025

Stifel initiates Foghorn Therapeutics stock with Buy rating, $12 target By Investing.com - Investing.com South Africa

Dec 03, 2025

Dec 03, 2025

Stifel initiates Foghorn Therapeutics stock with Buy rating, $12 target - Investing.com India

Dec 03, 2025

Dec 03, 2025

R/R Acute Myeloid Leukemia Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Foghorn Therapeutics, AB Science, Oncoceutics, Sanofi - Barchart.com

Dec 03, 2025

Dec 02, 2025

Published on: 2025-12-02 00:54:46 - Newser

Dec 02, 2025

Dec 01, 2025

Volatility Watch: Will Foghorn Therapeutics Inc stock deliver better than expected guidanceBond Market & Verified Momentum Stock Ideas - BỘ NỘI VỤ

Dec 01, 2025

Dec 01, 2025

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Average Recommendation of "Buy" from Analysts - MarketBeat

Dec 01, 2025

Dec 01, 2025

Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Average Recommendation of “Buy” from Analysts - Defense World

Dec 01, 2025

Nov 30, 2025

What analysts say about Foghorn Therapeutics Inc stockMarket Sentiment Extremes & Maximum Profit Growth - earlytimes.in

Nov 30, 2025

Nov 29, 2025

Foghorn Therapeutics (NASDAQ:FHTX) Upgraded at Wall Street Zen - MarketBeat

Nov 29, 2025

Nov 25, 2025

Foghorn Therapeutics CEO joins Evercore Healthcare Conference - Traders Union

Nov 25, 2025